- Inside the billion-dollar meeting for the mega-rich who want to live forever
- Biotech labs are using AI inspired by DALL-E to invent new drugs
- Here’s why we’re not prepared for the next wave of biotech innovation
- A bionic pancreas could solve one of the biggest challenges of diabetes
- How robotic honeybees and hives could help the species fight back
Why Cantos invests in engineering-led biology
The result is a widely anticipated landmark for rejuvenation technology.
Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of biology, machine learning, and biological engineering.
Two groups have announced powerful new generative models that can design new proteins on demand not seen in nature.
Hope, hype, and self-experimentation collided at an exclusive conference for ultra-rich investors who want to extend their lives past 100. I went along for the ride.
Robots that can monitor conditions in a hive, do a waggle dance, or even infiltrate the queen’s court could help scientists influence the health of a colony.
The device uses an algorithm to calculate a meal’s carbohydrates, then automatically releases insulin, taking those burdens off the patient.
The shift from biotech to TechBio enables us to do the most important things on earth: heal, feed, and provide for ourselves & our planet.
This is "biology's century," @matthewherper writes. But we’re approaching a moment when changes in what we understand are every bit as terrifying as exhilarating.
What actually is a techbio company?
Our in-depth reporting on innovation reveals and explains what’s really happening now to help you know what’s coming next. http://technologyreview.com/newsletters
The all-in-one workspace — for your tasks, notes, wikis, and calendar.
In-depth reporting on startup Europe, for startup Europe. 🇪🇺 Backed by the FT. Get the latest to your inbox: http://sifted.eu/newsletters
Data-driven reporting on private markets, startups, founders, and investors. Send tips to: firstname.lastname@example.org
Reporting from the frontiers of health & medicine. Sign up for any of our 10 free newsletters here: http://statnews.com/signup
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets 5 links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, add to reading list, save to «Made me smarter», «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Which sources does Refind monitor on techbio?
We monitor hundreds of sources on techbio, including MIT Technology Review, Notion, Sifted, Crunchbase News, STAT, and many more.
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to email@example.com
Who uses Refind?
100k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.